Grace Therapeutics, Inc. (GRCE) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading GRCE…

Grace Therapeutics, Inc. (GRCE) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Grace Therapeutics, Inc.

GRCE · CIK 1444192

4 · Sep 10, 2026 · Director, Chief Executive Officer Kohli Prashant bought 100K shares at $2.14/share ($214K)

4

Director, Chief Executive Officer Kohli Prashant bought 100K shares at $2.14/share ($214K)

Filed: Sep 10, 2026
Period: Sep 9, 2026
Accession: 0001140361-26-036125
Filer: Grace Therapeutics, Inc.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/form4.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4form4.xml
Open SEC.gov